Finance
Finance
HomeCORT • NASDAQ
Corcept Therapeutics Inc
$70.52
After Hours:
$70.52
(0.00%)0.00
Closed: Aug 6, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$70.45
Day range
$69.14 - $70.83
Year range
$33.34 - $117.33
Market cap
7.43B USD
Avg Volume
1.33M
P/E ratio
62.06
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Jun 2025Y/Y change
Revenue
194.43M18.70%
Operating expense
164.32M30.75%
Net income
35.15M-0.96%
Net profit margin
18.08-16.57%
Earnings per share
0.29-9.38%
EBITDA
26.96M-25.46%
Effective tax rate
-10.91%
Total assets
Total liabilities
(USD)Jun 2025Y/Y change
Cash and short-term investments
342.23M-27.67%
Total assets
801.72M12.20%
Total liabilities
165.93M40.25%
Total equity
635.79M
Shares outstanding
105.37M
Price to book
11.68
Return on assets
8.09%
Return on capital
10.01%
Net change in cash
(USD)Jun 2025Y/Y change
Net income
35.15M-0.96%
Cash from operations
43.94M6.69%
Cash from investing
70.13M216.50%
Cash from financing
-102.93M-4,687.63%
Net change in cash
12.93M161.08%
Free cash flow
33.50M-27.23%
About
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
Founded
May 13, 1998
Employees
500
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu